4
Changes in Ownership
Oncotelic Therapeutics, Inc. Filed Acc 0001209191-16-156108
Director bought 30,000 shares at an average $0.35 ($10,423)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Reynolds Donald Rogers Director | 2016-12-16 | Purchase | +12,700 | $0.34 | $4,318 | 12,700 | D: show line 1 in the form |
| Reynolds Donald Rogers Director | 2016-12-16 | Purchase | +7,350 | $0.35 | $2,573 | 20,050 | D: show line 2 in the form |
| Reynolds Donald Rogers Director | 2016-12-16 | Purchase | +9,950 | $0.36 | $3,532 | 30,000 | D: show line 3 in the form |
| Open-market purchases · 30,000 sh · avg $0.35 · $10,423 | |||||||
Loading xslF345X03/doc4.xml…